Document Detail


Orexin A affects ascending contraction depending on downstream cholinergic neurons and descending relaxation through independent pathways in mouse jejunum.
MedLine Citation:
PMID:  16762378     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The involvement of orexin in neural pathways for peristalsis was examined in mouse jejunal segments. Localized distension of the segments using a small balloon resulted in ascending contraction and descending relaxation. Ascending contraction was abolished by atropine and tetrodotoxin. Desensitization to orexin A (OXA) and SB-334867-A, an orexin-1 receptor antagonist, significantly inhibited ascending contraction. Hexamethonium also produced a significant inhibition. Exogenous administration of either OXA or nicotine induced a transient contraction that was completely inhibited by atropine and tetrodotoxin. The OXA-induced contraction was significantly inhibited by hexamethonium and SB-334867-A, whereas the nicotine-induced contraction was not inhibited by SB-334867-A. Descending relaxation was either partially or completely inhibited by l-nitroarginine and tetrodotoxin, respectively. Both SB-334867-A and hexamethonium partially inhibited descending relaxation. A combination of SB-334867-A and hexamethonium had an additive inhibitory effect on descending relaxation. Exogenous OXA, in the presence of atropine, induced a relaxation that was significantly inhibited by both l-nitroarginine and SB-334867-A, but not by hexamethonium. Nicotine in the presence of atropine relaxed the jejunal segment. SB-334867-A, unlike hexamethonium, did not affect nicotine-induced relaxation. These results suggest that OXA plays an important role in the ascending and descending neural reflexes in the mouse jejunum.
Authors:
Yuji Satoh; Yutaka Okishio; Yasu-Taka Azuma; Hidemitsu Nakajima; Fumiaki Hata; Tadayoshi Takeuchi
Related Documents :
2897218 - Mechanisms of action of lipoxygenase and cytochrome p-450-mono-oxygenase inhibitors in ...
6152268 - Electrical and mechanical responses of the bovine retractor penis to nerve stimulation ...
11959628 - 14,15-dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of k(...
12470968 - Vasodilatory effects of nipradilol, an alpha- and beta-adrenergic blocker with nitric o...
9144288 - Truncation of kir6.2 produces atp-sensitive k+ channels in the absence of the sulphonyl...
1756028 - Mitochondria, oxygen and reperfusion damage.
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-06-08
Journal Detail:
Title:  Neuropharmacology     Volume:  51     ISSN:  0028-3908     ISO Abbreviation:  Neuropharmacology     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-08-21     Completed Date:  2006-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0236217     Medline TA:  Neuropharmacology     Country:  England    
Other Details:
Languages:  eng     Pagination:  466-73     Citation Subset:  IM    
Affiliation:
Department of Veterinary Pharmacology, Graduate school of Life and Environmental Sciences, Osaka Prefecture University, Gakuen-cho 1-1, Sakai 599-9531, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcholine / metabolism*
Animals
Arginine / pharmacology
Benzoxazoles / pharmacology
Drug Interactions
Enzyme Inhibitors / pharmacology
Hexamethonium / pharmacology
Immunohistochemistry / methods
Intracellular Signaling Peptides and Proteins / pharmacology*
Jejunum / drug effects*,  physiology
Male
Mice
Mice, Inbred ICR
Models, Biological
Muscle Contraction / drug effects*,  physiology
Neural Pathways / cytology*
Neurons* / drug effects,  metabolism,  physiology
Neuropeptides / pharmacology*
Nicotinic Antagonists / pharmacology
Nitroarginine / pharmacology
Urea / analogs & derivatives,  pharmacology
Chemical
Reg. No./Substance:
0/1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea; 0/Benzoxazoles; 0/Enzyme Inhibitors; 0/Intracellular Signaling Peptides and Proteins; 0/Neuropeptides; 0/Nicotinic Antagonists; 0/orexins; 2149-70-4/Nitroarginine; 51-84-3/Acetylcholine; 57-13-6/Urea; 60-26-4/Hexamethonium; 74-79-3/Arginine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxi...
Next Document:  Influence of ambient temperature on peripherally induced interleukin-1 beta fever in young and old r...